BR100 Increased By (0.51%)
BR30 Increased By (0.59%)
KSE100 Increased By (0.35%)
KSE30 Increased By (0.28%)
BECO 6.08 Increased By ▲ 0.05 (0.83%)
BML 58.02 Increased By ▲ 5.27 (9.99%)
BOP 34.24 Decreased By ▼ -0.01 (-0.03%)
CNERGY 8.25 Increased By ▲ 0.09 (1.1%)
DCL 12.20 Decreased By ▼ -0.14 (-1.13%)
FCCL 54.35 Increased By ▲ 0.46 (0.85%)
FCSC 5.20 Decreased By ▼ -0.02 (-0.38%)
FFL 18.11 Increased By ▲ 0.08 (0.44%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.30 Increased By ▲ 0.30 (2.73%)
KEL 8.15 Increased By ▲ 0.04 (0.49%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 89.40 Increased By ▲ 1.35 (1.53%)
NBP 186.25 Decreased By ▼ -0.23 (-0.12%)
PACE 10.73 Increased By ▲ 0.01 (0.09%)
PAEL 40.36 Increased By ▲ 0.42 (1.05%)
PIAHCLA 26.38 Increased By ▲ 0.21 (0.8%)
PIBTL 17.45 Increased By ▲ 0.13 (0.75%)
PPL 233.80 Increased By ▲ 1.02 (0.44%)
PRL 34.94 Decreased By ▼ -0.01 (-0.03%)
PTC 66.94 Decreased By ▼ -0.62 (-0.92%)
SEARL 91.25 Increased By ▲ 0.32 (0.35%)
SSGC 27.19 Increased By ▲ 0.02 (0.07%)
TELE 8.60 Increased By ▲ 0.03 (0.35%)
THCCL 65.10 Increased By ▲ 4.97 (8.27%)
TPLP 9.08 Increased By ▲ 0.32 (3.65%)
TREET 24.80 Increased By ▲ 0.26 (1.06%)
TRG 73.10 Increased By ▲ 1.35 (1.88%)
WAVES 10.47 Increased By ▲ 0.49 (4.91%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
By

ISLAMABAD: Parliamentary Secretary, National Health Services Regulations and Coordination Dr Nausheen Hamid Sunday said that the coronavirus vaccine development was in its final stages as China has assured to provide 500,000 doses of Covid-19 vaccine to Pakistan by January 31.

The frontline staff will be the first ones to receive the COVID-19 vaccine and more than 3 lakh frontline workers have been identified to carry out vaccination process in first phase which is set to begin from end of February, she said while talking to a private news channel.

She said that Pakistan had approved Sinopharm vaccine for emergency use in Pakistan and expressed hope for its early availability from China, adding, the vaccine is being developed by CanSinoBio and the Beijing Institute of Biotechnology China.

Nausheen Hamid said the Chinese vaccine is also successfully undergoing phase 3 trials, adding, it was an “honor” for Pakistan to be among the few countries participating in “the biggest and relatively difficult” phase-3 study of a vaccine”.

She explained the first phase of the Covid-19 vaccination was dedicated for the frontline healthcare workers who were part of this challenge. In the second phase senior citizens aged 65 and over while in the third one the general population would be vaccinated.

She said government was under close contact with three international firms manufacturing the Covid-19 vaccine.

Comments

Comments are closed for this article.